Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19

2020; Frontiers Media; Volume: 7; Linguagem: Inglês

10.3389/fmed.2020.580677

ISSN

2296-858X

Autores

Ricardo Wesley Alberca, Milena Mary de Souza Andrade, Anna Cláudia Calvielli Castelo Branco, Anna Julia Pietrobon, Nátalli Zanete Pereira, Iara Grigoletto Fernandes, Luana de Mendonça Oliveira, Franciane Mouradian Emidio Teixeira, Danielle Rosa Beserra, Emily Araujo de Oliveira, Sarah Cristina Gozzi-Silva, Yasmim Álefe Leuzzi Ramos, Cyro Alves de Brito, Marcelo Arnone, Raquel Leão Orfali, Valéria Aoki, Alberto José da Silva Duarte, Maria Notomi Sato,

Tópico(s)

SARS-CoV-2 and COVID-19 Research

Resumo

Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+CD33+HLA-DR-CD14+ cells and CD11b+CD33+HLA-DR-CD66b+ cells.

Referência(s)